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Summary
The ability of Candida albicans to cause disease is
associated with its capacity to undergo morpho-
logical transition between yeast and filamentous
forms, but the role of morphology in colonization
and dissemination from the gastrointestinal (GI)
tract remains poorly defined. To explore this, we
made use of wild-type and morphological mutants
of C. albicans in an established model of GI tract
colonization, induced following antibiotic treat-
ment of mice. Our data reveal that GI tract coloni-
zation favours the yeast form of C. albicans, that
there is constitutive low level systemic dis-
semination in colonized mice that occurs irrespec-
tive of fungal morphology, and that colonization is
not controlled by Th17 immunity in otherwise
immunocompetent animals. These data provide
new insights into the mechanisms of pathogenesis
and commensalism of C. albicans, and have impli-
cations for our understanding of human disease.
Introduction
Candida albicans is a polymorphic fungus which grows in
both yeast and filamentous forms and resides as a com-
mensal in humans, particularly within the gastrointestinal
(GI) tract (Brown et al., 2012). However, C. albicans is
also an opportunistic pathogen and one of the major
aetiological agents of mucosal and systemic fungal infec-
tion (Brown et al., 2012). In susceptible individuals, sys-
temic C. albicans infections are thought to arise from
organisms in the GI tract; a hypothesis supported by data
from both patients and animal models (Koh et al., 2008;
Miranda et al., 2009). As filamentous forms predominate
at sites of primary epithelial infection, morphogenic tran-
sition is thought to facilitate access of C. albicans to the
bloodstream and subsequent systemic spread (Gow
et al., 2012). Moreover, morphogenetic transition is
essential for virulence of this pathogen as mutants locked
in either the yeast (Lo et al., 1997) or filamentous (Murad
et al., 2001) forms are highly attenuated in animal models
of systemic disease.
Given the importance of mucosal barriers, considerable
attention has been given to understanding the interactions
between C. albicans and epithelial cells. These studies
have generated evidence that hyphae, but not yeast, are
responsible for damaging and triggering protective inflam-
matory responses in epithelial cells (Moyes et al., 2010;
Wachtler et al., 2011). Moreover, hyphae can activate the
inflammasome leading to IL-1β production and induction
of the Th17 responses that are critical for protection at the
mucosa (Hise et al., 2009; Joly et al., 2009; Cheng et al.,
2011; Hernandez-Santos and Gaffen, 2012). Yet few
studies have investigated the role of C. albicans morphol-
ogy and host immunity during colonization of the GI tract
in vivo (White et al., 2007; Pande et al., 2013), which is
the focus of the studies presented herein.
Results and discussion
To study the role of C. albicans morphology and host
immunity during colonization of the GI tract, we made use
of an established model whereby antibiotic-treated mice
were colonized with C. albicans, following infection via
their drinking water (Supporting Information Fig. S1A)
(Vautier et al., 2012). Using this model, mice were
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infected with wild-type strains of C. albicans (SC5314 and
CAI4) as well as strains carrying mutations locking them
into the yeast (efg1Δ/cph1Δ) or filamentous forms (nrg1Δ).
Differences in GI colonization were characterized by
measuring stool fungal burdens at 7 and 10 days following
infection (Fig. 1A). Over this time frame, the level of GI
tract colonization remained constant for each strain,
similar to our previous observations (Vautier et al., 2012)
(Fig. 1A). Colonization with SC5314 was equivalent to
that of CAI4, the parental strain from which the mutant
strains were derived (Supporting Information Fig. S1B).
Notably, when compared with wild-type C. albicans, mice
infected with the yeast-locked efg1Δ/cph1Δ strain had
higher fungal burdens in the GI tract while the
filamentous-locked nrg1Δ strain colonized at lower levels
(Fig. 1A). Similar results were obtained with other mor-
phologically locked mutants, including yeast-locked
hgc1Δ and filamentous tup1Δ (Supporting Information
Fig. S1C). The lower colonization rates of the hyphal-
locked mutants were not due to differences in inoculum,
as we have previously shown GI tract colonization is not
affected by the inoculum level (Vautier et al., 2012).
To further confirm that the filamentous form of
C. albicans is not favoured in the GI tract, we utilized an
inducible filamentous strain (MBY38; tetO-UME6) in a
modified model of oral infection (Supporting Information
Fig. S1D). This strain is a conditional ume6 mutant, in
which UME6 is expressed in the absence of doxycycline,
driving filamentous growth (Carlisle et al., 2009). We also
infected mice with wild-type Candida to monitor for any
effects of doxycycline itself on colonization levels. In the
presence of doxycycline, MBY38 achieved similar coloni-
zation levels to SC5314, as measured by stool burdens
(Fig. 1B and Supporting Information Fig. S1E). However,
removal of doxycycline and induction of filamentous
growth on day 13 post infection led to a rapid decline in
colonization of this strain from the GI tract (Fig. 1B). Rein-
troduction of doxycycline at day 20 restored colonization
levels. In contrast, GI colonization by SC5314 was unaf-
fected by the presence or absence of doxycycline (Sup-
porting Information Fig. S1E).
We next investigated the ability of these mutants to
colonize tissues of the GI tract by analysing fungal
burdens at various sites on day 10 post infection
(Fig. 1C). All strains were detected throughout the GI tract
and generally reflected the levels found in the stools, i.e.
nrg1Δ-infected animals had lower tissue burdens while
efg1Δ/cph1Δ-infected animals had similar or higher tissue
burdens when compared with SC5314 or CAI4 (Fig. 1C
and Supporting Information Fig. S1F). Similarly, animals
infected with the filamentous form of MBY38 had
significantly lower tissue fungal burdens (Supporting
Information Fig. S1G). In the stomach, however, both
morphologically locked strains were present at lower
levels compared with SC5314, suggesting that the ability
to transition between morphologies is important for colo-
nization of this tissue (Fig. 1C).
Although our results for these C. albicans strains reflect
disparate observations made by several other groups
(Bendel et al., 2003; White et al., 2007; Koh et al., 2008;
Pierce and Kumamoto, 2012), it was possible that
morphotype-dependent levels of colonization were being
influenced through confounding effects of alterations in
co-regulated genes in these strains. Thus, to determine
the morphological preference in the GI tract in an unmodi-
fied strain, we enumerated the presence of yeast and
hyphal forms of wild-type C. albicans in the stools,
stomach and caecal contents of infected animals (Sup-
porting Information Fig. S1H). In all samples, C. albicans
was predominantly found as yeast. Thus, taken together,
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Fig. 1. Candida albicans morphology
influences colonization but not dissemination
from the GI tract.
A. Stool fungal burdens of 129Sv/Ev mice
infected with wild-type (SC5314), yeast
(efg1Δ/cph1Δ) and filamentous (nrg1Δ)
C. albicans strains at day 7 and day 10
following infection (n = 10 per group).
B. Stool fungal burdens of mice infected with
MBY38 (n = 5 per group), following treatment
with doxycycline, as indicated. The dotted
lines indicate time points where doxycycline
was administered or withdrawn.
C. Tissue fungal burdens in the kidneys,
stomach, small intestines (s. intest.), caecum
and large intestines (l. intest.) at day 10 post
infection with the fixed morphological mutants,
as indicated (n = 14 per group). ns, not
significant. *P < 0.05. See also Supporting
Information Fig. S1.
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these results strongly suggest that GI tract colonization
primarily favours the yeast form of C. albicans. In support
of this conclusion, C. albicans was recently found to
induce a novel yeast-like GUT (gastrointestinally induced
transition) morphotype, following colonization of the GI
tract (Pande et al., 2013). Why the yeast form is favoured
is unclear, but may reflect host immunity to the filamen-
tous forms, interaction with the microbiota and/or direct
physical influences under conditions of flow within the GI
tract.
Notably, we also found that C. albicans disseminated at
low levels to the kidneys following GI colonization
(Fig. 1C). Such dissemination has been reported previ-
ously (Kennedy and Volz, 1985; Samonis et al., 1990) and
also occurred at equivalent levels with the mutant strains,
which were highly attenuated in systemic infection models
(Supporting Information Fig. S1I), as expected (Lo et al.,
1997; Murad et al., 2001). Thus, these results show that
dissemination from the GI tract is not dependent on mor-
phological transition in C. albicans. How this dissemina-
tion occurs is unclear, as the intestinal epithelium is
covered by a thick layer of mucus preventing fungal
contact (de Repentigny et al., 2000; Johansson et al.,
2011; Iliev et al., 2012). Indeed, we could not detect
C. albicans cells in close proximity of the intestinal epithe-
lium by histology [data not shown (Iliev et al., 2012;
Vautier et al., 2012)]. Thus, transepithelial transport of
these organisms must be mediated by indirect mecha-
nisms, such as by lumen sampling dendritic cells
(Rescigno et al., 2001) or M cell transcytosis (Owen et al.,
1986; Rochereau et al., 2013). Such mechanisms could
explain how C. albicans can disseminate from the GI
tract, even in the absence of mucosal damage (White
et al., 2007; Koh et al., 2008; Vautier et al., 2012). Impor-
tantly, dissemination from the GI tract does not result in
systemic disease in immunologically competent animals
(data not shown).
We next determined if the various strains of C. albicans
differentially influenced host immunity by analysing
cytokine levels in various tissues at day 10 post infection.
However, we only detected altered cytokine levels in the
stomachs of infected animals with the morphologically
locked strains (Fig. 2A), which correlated with their
reduced tissue fungal burden (see Fig. 1C). Such differ-
ences were not observed in any other tissue (Supporting
Information Fig. S2A). This is consistent with our previous
observations demonstrating preferential infection of the
stomach in this model (Vautier et al., 2012) and the fact
that that colonization is restricted to the lumen elsewhere
in the GI tract (discussed above). Notably, the stomachs
of animals colonized with the morphologically locked
mutants had reduced levels of IL-1β, IL-6 and IL-17; all
of which are involved in mediating Th17 responses
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Fig. 2. Immune responses during GI tract colonization.
A. Selected cytokine levels in the stomachs of 129Sv/Ev mice at day 10 following infection with wild-type (SC5314), yeast-locked
(efg1Δ/cph1Δ) and filamentous-locked (nrg1Δ) C. albicans strains (n = 10 per group).
B. Day 6 stool fungal burdens of mice infected with wild-type (SC5314) and filamentous-locked (nrg1Δ) C. albicans strains, following daily
treatment with IL-1RA (Anakinra), as indicated (n = 5 per group).
C. Stool fungal burdens of C57BL/6 wild-type (n = 4 per group) or Il17A−/− (n = 5 per group) mice infected with MBY38 in the presence or
absence of doxycycline, as indicated. The dotted lines indicate time points where doxycycline was withdrawn. *P < 0.05. See also Supporting
Information Fig. S2.
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Th17 immunity is required for controlling C. albicans
infections at the mucosa, although the exact role of this
response at different mucosal sites, especially in the
GI tract, is controversial and poorly understood
(Hernandez-Santos and Gaffen, 2012). We therefore
explored the possibility that interfering with Th17
responses would alter GI tract colonization, particularly of
filamentous forms. As IL-1β is essential for controlling
systemic candidiasis (Vonk et al., 2006) and driving Th17
immunity (Hernandez-Santos and Gaffen, 2012), we first
blocked the effects of IL-1β by daily administration of an
IL-1 receptor antagonist (Anakinra) to mice and monitor-
ing stool fungal burdens (Fig. 2B and data not shown).
The i.p. administration of Anakinra has physiological
effects in the intestines at the doses used in our experi-
ments (Meinzer et al., 2012). Despite its importance in
systemic models (Vonk et al., 2006), blocking the IL-1
receptor had no effect on colonization levels of either
SC5314 or nrg1Δ. This suggests that IL-1 receptor signal-
ling is not involved in controlling GI tract colonization.
We then looked at the role of IL-17-related responses,
monitoring C. albicans colonization in the GI tract of both
IL17A−/− and IL17RA−/− mice (Fig. 2C and Supporting
Information Fig. S2B). For these experiments, we made
use of our inducible strain (MBY38) to examine the effects
on colonization by the filamentous morphotypes. Unex-
pectedly, we found no differences in C. albicans coloniza-
tion in either mouse knockout strain. As before, induction
of filamentous growth by withdrawal of doxycycline led to
rapid reduction in the fungal burdens in the GI tract, but
this was not significantly affected in the knockout mice.
Thus, although we cannot exclude a role for IL-22 (De
Luca et al., 2010), Th17 immunity does not appear to
regulate GI colonization by C. albicans.
In conclusion, our data show that in immunocompetent
animals the yeast form of C. albicans is favoured during
colonization of the GI tract, from which there is a consti-
tutive low level of systemic dissemination which is not
dependent on morphological transition. Moreover, we
show that colonization of the GI tract is not influenced by
Th17 immunity, indicating that other mechanisms of
control are occurring in these tissues. These data provide
new insights into the mechanisms of pathogenesis and
commensalism of C. albicans, and have implications for
our understanding of human disease.
Experimental procedures
Mice and ethics statement
Eight to twelve week old female 129Sv/Ev, C57BL/6, Il17a−/− and
Il17ra−/− mice on C57BL/6 background were bred and maintained
at specific pathogen-free facilities at the University of Aberdeen
and University of Pittsburgh. Mice were randomly allocated to
groups and housed in individually ventilated cages, and provided
with food and water ad libitum. All experimentation conformed to
the terms and conditions of United Kingdom Home Office
licenses for research on animals and the University of Aberdeen
and University of Pittsburgh ethical review committees.
Candida albicans strains, culture media and
growth conditions
Candida albicans strains used in this study included SC5314
(wild type), CAI4 (wild type), MBY38 [tetO-UME6 (Carlisle et al.,
2009)], efg1Δ/cphΔ1 (Lo et al., 1997), nrg1Δ (Murad et al., 2001),
hgc1Δ (Zheng and Wang, 2004) and tup1Δ (Braun and Johnson,
1997). Strains were routinely grown and maintained on YPD
agar (Sigma-Aldrich). For the MBY38 strain, plates contained
40 μg ml−1 of doxycycline. For inoculum preparation, a single
colony was grown in Sabouraud broth (Oxoid) at 30°C for 24 h
with shaking. Cells were washed twice in sterile phosphate-
buffered saline (PBS) and counted using a haemocytometer.
Inoculums of the filamentous strains, nrg1Δ and tup1Δ, were
standardized to 1 × 107 CFU ml−1 of SC5314 by quantifying
protein concentration (Meyers et al., 1998).
GI model
The GI model was performed essentially as described previously
(see Supporting Information Fig. S1) (Vautier et al., 2012). To
reduce commensal flora, mice were provided with sterile antibi-
otic water containing 2 mg ml−1 of streptomycin (Invitrogen),
2000 U ml−1 of penicillin (Invitrogen), 0.25 mg ml−1 of fluconazole
(Enzo) for 3 days and then switched to water containing the same
concentrations of streptomycin and penicillin for a further
24 h. Mice were then provided with sterile water containing
1 × 107 CFU ml−1 of C. albicans, 2 mg ml−1 of streptomycin and
2000 U ml−1 of penicillin for 5 days. After C. albicans exposure,
mice were maintained on sterile water containing 2 mg ml−1 of
streptomycin, 2000 U ml−1 of penicillin and 0.2 mg ml−1 of gen-
tamicin (Invitrogen). For strain MBY38, 2 mg ml−1 of doxycycline
was added in addition to the drinking water as detailed in Sup-
porting Information Fig. S1. To monitor colonization, stools were
collected from individual mice and homogenized in 1 ml of PBS,
serially diluted, and 25 μl of each dilution plated on YPD agar
containing 0.01 mg ml−1 of vancomycin (Sigma) and 0.1 mg ml−1
of gentamicin. Plates were incubated overnight at 37°C under
aerobic conditions and fungal levels determined by viable cell
count. Mice were killed at the indicated time points post exposure
to C. albicans. Kidney, stomach, small intestine, caecum and
large intestine samples (harvested in that order) were washed
three times with 1 ml of sterile PBS to remove gut contents.
Tissue weights were determined, and samples were transferred
into tubes containing 0.5 ml of PBS, 0.05% (v/v) Triton X-100 and
complete mini EDTA-free protease inhibitor cocktail (Roche). The
tissues were then homogenized, serially diluted and plated on
YPD as above. Cell debris was removed from the remaining
tissue homogenates by centrifugation at 15871 g for 15 min at
4°C and stored at −80°C for subsequent cytokine analysis.
IL-1R blocking
The GI model was performed essentially as above, except mice
were injected i.p. daily throughout the experiment with 50 mg kg−1
Kineret (Anakinra, UDG) (Sgroi et al., 2011) or PBS starting 2
days prior to infection.
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Cytokine analysis
Cytokine levels were measured using the Bio-Rad, Bio-Plex
Pro™ Mouse 23-Plex kit and analysed on the Bio-Plex system
using Bio-Plex Manager™ software as per manufacturer’s
instructions. Stored tissue sample supernatants were defrosted
and centrifuged for 15 min at 15871 g at 4°C to remove debris.
For each test, 50 μl of undiluted sample was used and cytokine
concentrations were normalized to sample protein concentrations
(BCA kit, Pierce).
Yeast/hyphae counts
Ten microlitres of samples from homogenized stools, stomach
and caecal contents were added to slides, coverslips applied
and Candida cells counted under a microscope at 40× magni-
fication. Four fields of view were counted per sample. The per-
centage of yeast/hyphae was then represented as a ratio of the
total number of cells counted (between 50 and 100 for every
field of view).
Statistical analysis
The two-tailed student’s t-test was used to compare two groups,
while multiple groups analyses were performed using two-way
analysis of variance (ANOVA). All data were analysed with
GraphPad Prism software version 5.04.
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Fig. S1. Candida albicans morphology influences colonization
but not dissemination from the GI tract. (A) Cartoon representa-
tion of the systemic experimental GI tract colonization model with
sampling points (underlined). (B) Stool fungal burdens of
129Sv/Ev mice infected with C. albicans SC5314 and CAI4 at
day 7 and day 10 following infection (n = 4 per group). (C) Stool
fungal burdens of 129Sv/Ev mice infected with wild-type
(SC5314), yeast (hgc1Δ) and filamentous (tup1Δ) C. albicans
strains at day 9 following infection (n = 6 per group). (D) Cartoon
representation of the modified GI tract colonization model with
doxycycline (dox) and C. albicans MBY38. (E) Stool fungal
burdens of 129Sv/Ev mice infected with SC5314, following treat-
ment with doxycycline, as indicated (n = 5 per group). The dotted
lines indicate the time intervals where doxycycline was adminis-
tered or withdrawn. (F) Tissue fungal burdens in the kidneys,
stomach, small intestines (s. intest.), caecum and large intestines
(l. intest.) at day 10 post infection with the wild strains, as indi-
cated (n = 4 per group). (G) Tissue fungal burdens in the kidneys,
stomach, small intestines (s. intest.), caecum and large intestines
(l. intest.) at day 20 post infection with SC5314 or MBY38, as
indicated (n = 5 per group). (H) Percentage yeast morphology of
C. albicans SC5314 and CAI4 in stools and in stomach and
caecum contents at day 10 post infection. (I) Survival of mice
following intravenous infection with (1 × 105) wild-type (SC5314),
yeast (efg1Δ/cph1Δ) or filamentous (nrg1Δ) C. albicans strains
(n = 6 per group). *P < 0.05.
Fig. S2. Immune responses during GI tract colonization. (A)
Selected cytokine levels in the caecum and large intestines of
129Sv/Ev mice at day 10 following infection with wild-type
(SC5314), yeast-locked (efg1Δ/cph1Δ) and filamentous-locked
(nrg1Δ) C. albicans strains, as indicated (n = 10 per group). (B)
Stool fungal burdens of wild-type C57BL/6 (n = 6) or Il17ra−/−
mice (n = 9) infected with MBY38, following treatment with or
without doxycycline, as indicated.
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